Clinical Trial Update: Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients [NA]

View source ↗

Summary

A randomized trial comparing Tenofovir disoproxil fumarate plus telbivudine versus monotherapy with either drug in HBeAg-negative chronic hepatitis B has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Telbivudine (telbivudine)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Chronic Hepatitis B | NA | Status: WITHDRAWN